Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander W Tas

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|March 6, 2026
Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'Haiyu Wang, Saskia Nugteren, Rick Groenland, et al.
Frontiers in Immunology|February 21, 2022
Folate Receptor Beta for Macrophage Imaging in Rheumatoid ArthritisMaarten M Steinz, Aiarpi Ezdoglian, Fatemeh Khodadust, et al.
Expert Opinion on Drug Safety|August 5, 2021
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomesLeanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
The Lancet. Rheumatology|March 3, 2021
Perspective of patients with autoimmune diseases on COVID-19 vaccinationLaura Boekel, Femke Hooijberg, Zoé L E van Kempen, et al.
Expert Opinion on Drug Safety|February 16, 2023
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesHelen R Gosselt, Jette A van Lint, Leanne J Kosse, et al.
Annals of the Rheumatic Diseases|December 4, 2018
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI studyDanielle M Gerlag, Mary Safy, Karen I Maijer, et al.
Expert Opinion on Drug Safety|August 29, 2022
Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort studyLieke H Roest, Leanne J Kosse, Jette A van Lint, et al.
Journal of Pharmaceutical Sciences|February 3, 2022
Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell ImmunotherapyNoémi Anna Nagy, Charlotte Castenmiller, Fernando Lozano Vigario, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 19, 2023
Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis ModelMerlijn H Kaaij, Jan Piet van Hamburg, Charlotte C N van Rooijen, et al.
Frontiers in Immunology|January 30, 2019
Maturing Human CD127+ CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted AntigensJoannah R Fergusson, Michael D Morgan, Melanie Bruchard, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|March 6, 2026
Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'Haiyu Wang, Saskia Nugteren, Rick Groenland, et al.
Frontiers in Immunology|February 21, 2022
Folate Receptor Beta for Macrophage Imaging in Rheumatoid ArthritisMaarten M Steinz, Aiarpi Ezdoglian, Fatemeh Khodadust, et al.
Expert Opinion on Drug Safety|August 5, 2021
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomesLeanne J Kosse, Gerda Weits, Harald E Vonkeman, et al.
The Lancet. Rheumatology|March 3, 2021
Perspective of patients with autoimmune diseases on COVID-19 vaccinationLaura Boekel, Femke Hooijberg, Zoé L E van Kempen, et al.
Expert Opinion on Drug Safety|February 16, 2023
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesHelen R Gosselt, Jette A van Lint, Leanne J Kosse, et al.
Annals of the Rheumatic Diseases|December 4, 2018
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI studyDanielle M Gerlag, Mary Safy, Karen I Maijer, et al.
Expert Opinion on Drug Safety|August 29, 2022
Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort studyLieke H Roest, Leanne J Kosse, Jette A van Lint, et al.
Journal of Pharmaceutical Sciences|February 3, 2022
Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell ImmunotherapyNoémi Anna Nagy, Charlotte Castenmiller, Fernando Lozano Vigario, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 19, 2023
Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis ModelMerlijn H Kaaij, Jan Piet van Hamburg, Charlotte C N van Rooijen, et al.
Frontiers in Immunology|January 30, 2019
Maturing Human CD127+ CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted AntigensJoannah R Fergusson, Michael D Morgan, Melanie Bruchard, et al.
Pageof 15